Inspira to open South Jersey's first inpatient detox unit
The health system invested $1.4M to convert space previously used for hospice care to a medical detoxification and addiction treatment unit.
Fatal drug overdoses peaked last year, according to preliminary data from the CDC, fueling hope that the deadliest addiction in American history has finally stalled. But fatalities are only part of the ongoing crisis. Tony Dokoupil reports.
"I come from a good family. I work 40 to 50 hours a week," a young man named Jacob said
Conclusion: Substitution of parenteral thiamine in individuals with suspected WE is a well-established treatment regimen. However, suggestions according to guidelines vary widely. Furthermore, hardly any evidence-based recommendations exist on a more general use of thiamine as a preventative intervention in individuals with AUD. Further research is of utmost importance to raise awareness for this potentially undervalued problem.Eur Addict Res 2019;25:103 –110
Conclusions: Lifetime cannabis use is associated with better working memory and processing speed and worse real-world functioning in the area of socially useful activities in patients with schizophrenia-related disorders. Clinicians should, therefore, be aware of it to provide patient-centred care in their daily clinical practice.Eur Addict Res 2019;25:111 –118
Thread Starter Suitable volunteering for medicine?? Follow 6 hours ago 6h ago Quote: Originally Posted by Amneet k Hello I want to apply to medicine and was looking for a long term volunteering placement when I came across a charity that goes out and helps the homel...
The rise in the use of opioids has been accompanied by escalating rates of prescription opioid misuse and addiction in patients with pain. Research has shown that opioid craving is a robust determinant of prescription opioid misuse. There is reason to believe that hedonic feelings associated with opioid use (e.g., pleasure, satisfaction) could also contribute to opioid misuse. However, this has yet to be examined in patients with pain. In this longitudinal study, the first objective was to examine the association between opioid-related hedonic feelings and prescription opioid misuse in patients with chronic pain.
Approximately 70% SCI patients report chronic pain, with a third characterizing their pain as debilitating. SCI-NP accompanies 40%-60% of SCI cases and is regarded as more severe than nociceptive pain. SCI-NP remains minimally responsive to existing pharmacological and nonpharmacological treatments. Pharmacological agents (e.g., antidepressants, antiepileptics, opioids) provide only a third of patients ’ 50% pain reduction and present significant side effects including constipation, toxification, and addiction.
Before the height of the opioid crisis, research had well-established older Blacks ’ reluctance to use opioids due to concerns about side effects, addiction, and overdose. Our study found that 30% of Blacks used opioid medications within the past 30 days to manage joint pain. Given this proportion of users, we investigated demographic, social, clinical, and behavioral patterns d istinguishing opioid consumers and non-consumers. Descriptive statistics, chi-square, one-way ANOVA, and qualitative content analysis summarize data for community-dwelling Black adults (≥50 years age) with symptomatic osteoarthritis.
Chronic low back pain symptoms are extremely common among Iraq/Afghanistan-era Veterans. However, pharmacological management for pain is frequently suboptimal, and many Veterans experience persistent and unalleviated pain symptoms and/or intolerable side effects to pain medications. Current medications such as opioids that are frequently used to treat chronic pain symptoms have side effect risks such as respiratory depression, addiction, sedation, and potentially lethal interactions with other drugs. There is thus an acute and immediate need for the development of effective, safe, and non-habit-forming pharmacologica...
The development of analgesic tolerance to opioid pharmacotherapies presents a persistent issue in the treatment of chronic pain, resulting in dose escalation and increased risk for dependence and respiratory depression. Recent studies have demonstrated the involvement of peripheral opioid receptors in the development of opioid tolerance to classical opioids like morphine and oxycodone. There have also been reports of differences in opioid analgesia, tolerance and addiction between males and females.